Renovion
Renovion Receives Notice of Study May Proceed Status for Lung Transplant Program
Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for serious chronic inflammatory lung diseases...
top of page
News
Search
Renovion
- Jan 6, 2017
- 2 min
Renovion Receives Orphan Designation for ARINA-1 for the treatment of Lung Dysfunction
Renovion, Inc. ("Renovion"), an early stage drug development company targeting the treatment of lung transplant and other chronic...
bottom of page